NCT00022399 2019-02-08
Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
Clinical Trials
8 trialsNCT00080782 2018-10-31
Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01220973 2018-06-08
Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT02840162 2017-04-28
Pre-Prostatectomy Celecoxib or Placebo
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT01678313 2014-07-15
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
Buddhist Tzu Chi General Hospital
Phase 2 Completed
NCT00073970 2012-05-23
Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
UNC Lineberger Comprehensive Cancer Center
Phase 2 Terminated
NCT00215345 2005-09-22
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
Department of Veterans Affairs, New Jersey
Phase 2 Unknown
NCT00218205 2005-09-22
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Department of Veterans Affairs, New Jersey
Phase 2 Unknown